China NMPA Product Recall - Low ionic strength salt solutions

The National Medical Products Administration (NMPA) published a recall notice on July 1, 2014, concerning a voluntary recall initiated by Ortho-Clinical Diagnostics (UK) for a batch of its low ionic strength saline solution (Registration Certificate No.: CFDA (Imported) No. 20131403528). The report, submitted by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. on June 19, 2014 (reporting date June 17, 2014), detailed the discovery of mold, specifically Cladosporium spp., in unopened bottles of product batch number 280397. This specific solution, identified by model/specification 707116, is a critical component used with the Ortho BioVue® system for in vitro diagnostics. Crucially, the manufacturer confirmed that the affected batch (batch number 280397) had an import quantity of zero and was not sold within the Chinese market. Consequently, Johnson & Johnson (Shanghai) indicated that, beyond the initial notification to the State Food and Drug Administration, no further investigative or corrective actions, such as submitting evaluation reports, implementation plans, or summary reports, would be undertaken in China, given the absence of market exposure. Despite no sales in China, the NMPA proactively requested all provincial and municipal food and drug administrations to enhance their supervision and management over similar medical products to ensure ongoing safety and quality across the industry. This case illustrates a global recall with specific localized regulatory responses based on product distribution.